-
Live Updates: Fox News Settles Defamation Suit for $787.5 Million, Dominion Says
Fox News reached a last-minute settlement with Dominion Voting Systems, which accused Fox News of pushing conspiracies that harmed the company.
-
Apple Opens First Store in India, a Promising Frontier for the Tech Giant
Tim Cook, the chief executive of the iPhone maker, visited Mumbai to inaugurate the store. Apple is pushing to expand its market share in India, as well as shift some production there.
-
Reddit Wants to Get Paid for Helping to Teach Big A.I. Systems
The internet site has long been a forum for discussion on a huge variety of topics, and companies like Google and OpenAI have been using it in their A.I. projects.
-
With ‘Zero Covid’ Behind It, China’s Economy Starts to Recover
The economy grew 4.5 percent in the first three months of the year, a sizable pickup from the end of 2022, when the relaxation of pandemic prevention measures led to a wave of illness.
-
Proud Boy who broke Capitol window: ‘I got caught up in all the craziness’
Dominic Pezzola is the last defense witness to testify at the trial of five Proud Boys accused of plotting violence on Jan. 6.
-
Supreme Court seeks compromise in ex-mailman’s Sabbath-work conflict
Gerald Groff, an evangelical Christian, loved being a mail carrier because he could have Sundays off. Then the postal service began Sunday delivery for Amazon.
-
Democrats still face Feinstein dilemma as replacement bid fails
But the 89-year-old senator enjoys the support of powerful allies, including President Biden and Nancy Pelosi.
-
4 takeaways from the Dominion v. Fox settlement
There will be no trial. But we learned plenty. And there’s more to come.
-
Trump’s post-indictment GOP rallying effect is real
It’s not just his gains on Florida Gov. Ron DeSantis. And we now have multiple data points reinforcing it.
-
Biden Administration Will Fund Program to Keep Covid Vaccines Free for the Uninsured
The program, which will include a partnership with pharmacy chains, will help cover the costs of vaccinating patients when the shots move to the commercial market later this year.